Literature DB >> 22127750

Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study.

Nicola Gilberti1, Marinella Turla, Antonella Alberici, Valeria Bertasi, Patrizia Civelli, Silvana Archetti, Alessandro Padovani, Barbara Borroni.   

Abstract

The study of neurodegenerative diseases, such as frontotemporal lobar degeneration (FTLD), in isolated populations represents a privileged point of view for identifying new causative genes and pathogenetic mechanisms. Vallecamonica is a valley located in the Brescia province (Northern Italy), which experienced isolation until the end of World War II. The aims of the present work were (1) to estimate the prevalence of FTLD in Vallecamonica, (2) to determine the monogenic FTLD forms, and (3) to identify FTLD cases with no evidence of known pathogenetic mutations and the related clinical features. Patients meeting current clinical criteria for FTLD were considered. Mutation analysis for microtubule associated protein tau (MAPT) and progranulin (PGRN) genes was performed, as well as serum PGRN dosage. On the census day, 42 FTLD patients were alive, resulting in an overall disease prevalence of 35 per 100 inhabitants. Thirty-one out of 42 patients underwent sequencing analysis. Five patients carried PGRN Thr272fs mutation and one patient MAPT P301L mutation. There were no differences in term of age at onset and gender between this group and mutation carriers, but the latter had greater family history for dementia (100%, P = 0.01). In Vallecamonica, we detected a higher prevalence of FTLD compared with that already reported in other populations. A founder effect or a genetic drift might be considered for an allelic enrichment. Ongoing study aims to identify the presence of a new genetic form in those FTLD patients without known pathogenetic mutations in this isolated population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127750     DOI: 10.1007/s10072-011-0865-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Prevalence of TAU mutations in an Italian clinical series of familial frontotemporal patients.

Authors:  Giuliano Binetti; Francesca Nicosia; Luisa Benussi; Roberta Ghidoni; Enrica Feudatari; Laura Barbiero; Simona Signorini; Aldo Villa; Flavia Mattioli; Orazio Zanetti; Antonella Alberici
Journal:  Neurosci Lett       Date:  2003-02-20       Impact factor: 3.046

2.  Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy.

Authors:  Barbara Borroni; Antonella Alberici; Mario Grassi; Marinella Turla; Orazio Zanetti; Angelo Bianchetti; Giorgio Dalla Volta; Renzo Rozzini; Nicola Gilberti; Giuseppe Bellelli; Alessandro Padovani
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.

Authors:  Gaia Skibinski; Nicholas J Parkinson; Jeremy M Brown; Lisa Chakrabarti; Sarah L Lloyd; Holger Hummerich; Jørgen E Nielsen; John R Hodges; Maria Grazia Spillantini; Tove Thusgaard; Sebastian Brandner; Arne Brun; Martin N Rossor; Anders Gade; Peter Johannsen; Sven Asger Sørensen; Susanne Gydesen; Elizabeth M C Fisher; John Collinge
Journal:  Nat Genet       Date:  2005-07-24       Impact factor: 38.330

4.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

5.  The evolution and pathology of frontotemporal dementia.

Authors:  Andrew Kertesz; Paul McMonagle; Mervin Blair; Wilda Davidson; David G Munoz
Journal:  Brain       Date:  2005-07-20       Impact factor: 13.501

6.  TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration.

Authors:  Lina Benajiba; Isabelle Le Ber; Agnès Camuzat; Mathieu Lacoste; Catherine Thomas-Anterion; Philippe Couratier; Solenn Legallic; François Salachas; Didier Hannequin; Marielle Decousus; Lucette Lacomblez; Eric Guedj; Véronique Golfier; William Camu; Bruno Dubois; Dominique Campion; Vincent Meininger; Alexis Brice
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

Authors:  R Ghidoni; L Benussi; M Glionna; M Franzoni; G Binetti
Journal:  Neurology       Date:  2008-09-03       Impact factor: 9.910

8.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

9.  Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series.

Authors:  Barbara Borroni; Silvana Archetti; Antonella Alberici; Chiara Agosti; Massimo Gennarelli; Barbara Bigni; Cristian Bonvicini; Maria Ferrari; Giuseppe Bellelli; Daniela Galimberti; Elio Scarpini; Diego Di Lorenzo; Luigi Caimi; Carlo Caltagirone; Monica Di Luca; Alessandro Padovani
Journal:  Neurogenetics       Date:  2008-04-08       Impact factor: 2.660

10.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

View more
  7 in total

Review 1.  The epidemiology of frontotemporal dementia.

Authors:  Chiadi U Onyike; Janine Diehl-Schmid
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 2.  Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Authors:  Anjali N Patel; Jacinda B Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2015-09       Impact factor: 5.081

Review 3.  Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy.

Authors:  Nilton Custodio; Ana Wheelock; Daniela Thumala; Andrea Slachevsky
Journal:  Front Aging Neurosci       Date:  2017-07-13       Impact factor: 5.750

4.  Prevalence of frontotemporal dementia in community-based studies in Latin America: a systematic review.

Authors:  Nilton Custodio; Eder Herrera-Perez; David Lira; Rosa Montesinos; Liliana Bendezu
Journal:  Dement Neuropsychol       Date:  2013 Jan-Mar

5.  Differences in Sex Distribution Between Genetic and Sporadic Frontotemporal Dementia.

Authors:  Sterre C M de Boer; Lina Riedl; Sven J van der Lee; Markus Otto; Sarah Anderl-Straub; Ramon Landin-Romero; Federica Sorrentino; Jay L P Fieldhouse; Lianne M Reus; Blanca Vacaflor; Glenda Halliday; Daniela Galimberti; Janine Diehl-Schmid; Simon Ducharme; Olivier Piguet; Yolande A L Pijnenburg
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Epidemiology of Frontotemporal Lobar Degeneration in Northern Finland.

Authors:  Laura Luukkainen; Risto Bloigu; Virpi Moilanen; Anne Marja Remes
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-11-24

7.  Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes.

Authors:  Ian T S Coyle-Gilchrist; Katrina M Dick; Karalyn Patterson; Patricia Vázquez Rodríquez; Eileen Wehmann; Alicia Wilcox; Claire J Lansdall; Kate E Dawson; Julie Wiggins; Simon Mead; Carol Brayne; James B Rowe
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.